Steven Cohen’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLYS
Steven Cohen's MLYS Position: Q3 2026 in Review
Steven Cohen opened a new position in Mineralys Therapeutics (MLYS) in Q3 2026: 1,269,350 shares worth $31.9M. The stake represents 0.04% of the portfolio and ranks #658 among its holdings. This is a return to the name: Steven Cohen previously reported a position in MLYS as recently as Q1 2026.
Steven Cohen first reported a position in MLYS in Q1 2023 and has held it in 9 quarters since. The position peaked at $68.2M in Q3 2025. 217 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.
- Steven Cohen held 1,269,350 shares of Mineralys Therapeutics worth $31.9M as of Q3 2026.
- Mineralys Therapeutics was a new Steven Cohen position in Q3 2026.
- Mineralys Therapeutics made up 0.04% of Steven Cohen's portfolio in Q3 2026, its #658 holding.
- Steven Cohen first reported a position in Mineralys Therapeutics in Q1 2023 and has held it in 9 quarters since.
- Steven Cohen's Mineralys Therapeutics position peaked at $68.2M in Q3 2025.
- 217 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.